1369838-81-2

Upstream product

• 400-94-2 4-fluoro-3-nitrobenzoyl chloride 
• 453-71-4 3-nitro-4-fluorobenzoic acid 
• 349-02-0 4-fluoro-3-nitrobenzamide 
• 67-63-0 isopropyl alcohol 

Downstream Products

• 1153956-60-5 3-Amino-4-isopropoxy-benzamide 
• 1378078-72-8 4-Isopropoxy-3-[3-(2-oxo-2,3-dihydro-1H-benzoimidazol-4-yl)-thioureido]-benzamide 
• 1378078-73-9 3-[3-(2-chloro-1H-benzoimidazol-4-yl)thioureido]-4-isopropoxy-benzamide 
• 1377579-12-8 3-(5-Bromo-2',4'-dimethyl-[4,5']bithiazolyl-2-ylamino)-4-isopropoxy-benzamide 
• 1377581-81-1 3-(2'-chloromethyl-4'-methyl-[4,5']bithiazolyl-2-ylamino)-4-isopropoxy-benzamide 

Relevant academic research and scientific papers

TRICYCLIC INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION

This invention relates to tricycle I and its therapeutic and prophylactic uses, wherein the variables C1, C2, Z1, Z2, Q, J, R1, and R3 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.

PHENYL-THIAZOLYL INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION

This invention relates to phenyl thiazole I and its therapeutic and prophylactic uses, wherein the variables Rz, Q, J, R1, R3, R5, R6, and R7 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.

BIS HETEROARYL INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION

This invention relates to thiazole I and its therapeutic and prophylactic uses, wherein the variables A, Q, J, R1, R3, and R5 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.

FUSED HETEROARYL INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION

This invention relates to thiazole I and its therapeutic and prophylactic uses, wherein the variables A, Q, J, R1, R3, and R5 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.

PYRIDYL-THIAZOLYL INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION

This invention relates to thiazole I and its therapeutic and prophylactic uses, wherein the variables Rz, Q, J, R1, R3, R5, and R6 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.

BISTHIAZOLE INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION

This invention relates to bisthiazole I and its therapeutic and prophylactic uses, wherein the variables A, R5, R6, and R7 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.